Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

ICOS Corporation

ICOS has spent more than a decade building a world-class research and development organization. Now, with Cialis® available worldwide and several candidates in the pipeline, ICOS is poised to establish a powerful commercial presence.The world's healthcare needs are more pressing than ever. Not only has the global population expanded by more than 800 million people in the last decade, but the median age continues to grow older as well. At ICOS, our mission is to target serious unmet medical needs -- and to address those needs with novel, effective products that can improve the quality of life for millions of people


Contact Details:
22021 20th Avenue SE
Bothell
Washington
98021
United States of America
Tel:425.485.1900
Fax:425.489.0356
Email:info@icos.com
WWW:

www.icos.com/




Loading...

Recent Publications by ICOS Corporation:

Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.
BACKGROUND AND PURPOSE: Post-synaptic density protein 95 (PSD95) contains...
8th September, 2009
ICOS Corporation, Bothell, WA, USA. Br J Pharmacol. 2009 Sep;158(2):494-506.
DOI Direct Link
Regulation of fibrosis by the immune system.
Inflammation and fibrosis are two inter-related conditions with many...
30th April, 2009
ICOS Corporation, Bothell, Washington, USA. Adv Immunol. 2006;89:245-88.
DOI Direct Link
Novel tools for functional analysis of CD11c: activation-specific, activation-independent, and activating antibodies.
Functions and binding properties of four CD11c-specific mAbs are described...
1st April, 2008
ICOS Corporation, J Immunoassay Immunochem. 2008;29(1):42-57.
DOI Direct Link
CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity.
CD11c, a member of the leukointegrin family, is expressed prominently on...
18th September, 2007
ICOS Corporation, 22021 20th Ave., S.E., Bothell, WA 98021, USA. J Leukoc Biol. 2007 Jun;81(6):1395-403. Epub 2007 Mar 27.
DOI Direct Link
Enhancement of Natural Killer cell cytotoxicity by a CD18 integrin-activating antibody.
Natural Killer (NK) cells kill certain tumor cells and virus infected...
21st July, 2007
ICOS Corporation, 22021 20th Avenue SE, Bothell, WA 98021, USA. Biochem Biophys Res Commun. 2007 Jul 6;358(3):938-41. Epub 2007 May 14.
DOI Direct Link

View more ICOS Corporation research publications.

Press Releases on ICOS Corporation:

BioPortfolio Logo
Oncothyreon appoints Scott Peterson as Vice President of Research and Development 15th June, 2009 Oncothyreon Inc.
SEATTLE, June 15 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY) (the "Company") today announced the appointment of Scott Peterson, Ph.D., as Vice President, Research and

BioNews Results for ICOS Corporation:

The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News
Seattle Post Intelligencer:  Nov 20 2009 7:13AM Matching: icos
The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News
Xconomy:  Nov 19 2009 7:14AM Matching: icos
The Icos Alumni: Where Are They Now?
Xconomy:  Nov 18 2009 1:32PM Matching: icos
An Ode to Schering-Plough
Motley Fool via MSN Money:  Nov 4 2009 11:52PM Matching: icos
An Ode to Schering-Plough
Motley Fool:  Nov 4 2009 9:45PM Matching: icos
Promote your company here: BioNewsCast - Press Release Distribution

View more ICOS Corporation news.

ICOS Corporation Clinical Trials:

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

ICOS Corporation Patents:

US Patent No.Title
6790947 Polynucleotides encoding macrophage derived chemokine
6911542 Pyrazino[1',2':1,6]pyrido[3,4b]indole derivatives
6924284 PARP inhibitors
6943166 Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
6949535 Inhibitors of human phosphatidyl-inositol 3-kinase delta

View more ICOS Corporation patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 23 individuals from ICOS Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 398 times since April 2007, the link to the organisation's website has been followed 69 times

Recent Search Terms used to find this page: ICOS Corporation contact information | icos corporation | ICOS Corp | ICOS corp | ICOS corporation | icos corp seattle | ICOS Corporation | .

Search for more companies in Bothell

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ICOS Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.